Business Segments · Research and development - external
Business Segments — Research and development - external
Incyte Business Segments — Research and development - external decreased by 10.7% to $243.13M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.7%, from $193.43M to $243.13M. Over 3 years (FY 2022 to FY 2025), Business Segments — Research and development - external shows an upward trend with a 10.4% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2022
Last reportedQ1 2026Apr 28, 2026
How to read this metric
An increase suggests an acceleration of clinical development programs or reliance on external expertise to reach milestones.
Detailed definition
This represents payments made to third-party contract research organizations (CROs), academic institutions, and clinical...
Peer comparison
Commonly used by peers to distinguish between internal capacity and outsourced clinical trial execution.
Metric ID:
incy_segment_reportable_segment_research_and_development_externalHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $180.05M | $180.05M | $180.05M | $180.05M | $193.98M | $193.98M | $193.98M | $193.98M | $205.16M | $223.94M | $222.70M | $213.20M | $193.43M | $245.68M | $256.34M | $272.39M | $243.13M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +7.7% | +0.0% | +0.0% | +0.0% | +5.8% | +9.2% | -0.6% | -4.3% | -9.3% | +27.0% | +4.3% | +6.3% | -10.7% |
| YoY Change | — | — | — | — | +7.7% | +7.7% | +7.7% | +7.7% | +5.8% | +15.4% | +14.8% | +9.9% | -5.7% | +9.7% | +15.1% | +27.8% | +25.7% |
Range$180.05M – $272.39M
CAGR+7.8%
Avg YoY Growth+11.5%
Median YoY Growth+9.7%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Incyte's business segments — research and development - external?
- Incyte (INCY) reported business segments — research and development - external of $243.13M in Q1 2026.
- How has Incyte's business segments — research and development - external changed year-over-year?
- Incyte's business segments — research and development - external increased by 25.7% year-over-year, from $193.43M to $243.13M.
- What is the long-term trend for Incyte's business segments — research and development - external?
- Over 3 years (2022 to 2025), Incyte's business segments — research and development - external has grown at a 10.4% compound annual growth rate (CAGR), from $720.20M to $967.85M.
- What does business segments — research and development - external mean?
- The cost of outsourcing research and clinical trial activities to external partners.